Fingerprint
Dive into the research topics of 'A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically